Loading...
Market
What will be the investment amount announced in the first WHO-EIB primary healthcare project by the end of 2024?
2
World Health Organization•WHO•European Investment Bank•EIB•first Investment Round•WHO Foundation Board
Resolution / Starting Odds
Less than $50 million • 25%
$50 million to $100 million • 25%
$100 million to $150 million • 25%
More than $150 million • 25%
WHO and EIB official announcements and press releases
Story
WHO Prequalifies First Hepatitis C Self-Test on Wednesday, Signs Framework Agreement with EIB
Jul 11, 2024, 08:54 AM
The World Health Organization (WHO) announced on Wednesday that it has prequalified the first self-test for the hepatitis C virus (HCV), marking a significant step towards the global elimination of the virus. This milestone is expected to expand access to testing and diagnosis, which is crucial for the prevention, detection, and treatment of hepatitis C. The self-test aims to facilitate early diagnosis and treatment, contributing to the broader goal of total elimination of the viral infection. Additionally, WHO has signed its first framework agreement with the European Investment Bank (EIB) to support primary healthcare investments in low and middle-income countries. This partnership is part of WHO's strategy to promote health for all and enhance global health infrastructure. Furthermore, WHO's first Investment Round has been discussed with the WHO Foundation Board to ensure its success.
View original story
Similar markets
Less than $1 billion • 25%
$1 billion to $1.5 billion • 25%
$1.5 billion to $2 billion • 25%
More than $2 billion • 25%
Less than $1 billion • 25%
$1 billion to $3 billion • 25%
More than $3 billion • 25%
No further support • 25%
European Union • 25%
China • 25%
Private Foundations • 25%
Other • 25%
€10 million • 25%
€10-20 million • 25%
€20-30 million • 25%
More than €30 million • 25%
Government grants • 25%
Private donations • 25%
International organizations • 25%
Corporate sponsorships • 25%
€0-€200 billion • 25%
€200-€400 billion • 25%
€400-€600 billion • 25%
€600-€800 billion • 25%
Government grants • 25%
Private donations • 25%
Pharmaceutical companies • 25%
International organizations • 25%
Less than £40 billion • 25%
£40 billion to £50 billion • 25%
£50 billion to £60 billion • 25%
More than £60 billion • 25%
€0-€250 billion • 25%
€250-€500 billion • 25%
€500-€750 billion • 25%
€750 billion+ • 25%
